Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress towards hematopoietic stem cell gene therapy.

P Kurre1, H P Kiem

  • 1Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109-1024, USA.

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers.

Nature communications·2017
Same author

Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes.

Leukemia·2015
Same author

Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.

Pediatric hematology and oncology·2012
Same author

Myelodysplasia in 2 pig-tailed macaques (Macaca nemestrina) associated with retroviral vector-mediated insertional mutagenesis and overexpression of HOXB4.

Veterinary pathology·2010
Same author

Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.

Bone marrow transplantation·2010
Same author

Paroxysmal nocturnal haemoglobinuria clones are part of the immune dysregulation in hepatitis-associated aplastic anaemia.

Alimentary pharmacology & therapeutics·2009
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Gene therapy shows promise for treating diseases by introducing genetic material into human cells. Recent advancements improve hematopoietic stem cell gene transfer, but challenges remain for clinical application.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Hematology

Background:

  • Gene therapy holds significant potential for treating human diseases.
  • Historically, a gap has existed between gene therapy's promise and its clinical realization.
  • Understanding gene transfer systems is crucial for effective therapeutic applications.

Purpose of the Study:

  • To review recent advancements in hematopoietic stem cell gene transfer.
  • To highlight promising clinical outcomes in gene therapy applications.
  • To identify persistent challenges in the field of gene therapy.

Main Methods:

  • Review of scientific literature over the past 15 years.
  • Analysis of gene transfer systems and their efficiency.
  • Evaluation of clinical trial data and outcomes.

Related Experiment Videos

Main Results:

  • Significant improvements have been made in hematopoietic stem cell gene transfer techniques.
  • Several clinical applications have shown promising therapeutic results.
  • Obstacles to widespread and effective gene therapy implementation persist.

Conclusions:

  • Hematopoietic stem cell gene transfer is a rapidly evolving field with increasing clinical success.
  • Continued research is necessary to overcome existing impediments and fully realize gene therapy's potential.
  • The review provides insights into current progress and future directions for gene therapy research and application.